These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23559127)

  • 21. Optimised photodynamic diagnosis for transurethral resection of the bladder (TURB) in German clinical practice: results of the noninterventional study OPTIC III.
    Bach T; Bastian PJ; Blana A; Kaminsky A; Keller S; Knoll T; Lang C; Promnitz S; Ubrig B; Keller T; Qvick B; Burger M;
    World J Urol; 2017 May; 35(5):737-744. PubMed ID: 27578233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of high-risk non-muscle invasive bladder cancer.
    Brausi M; Olaru V
    Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macro and microeconomics of blue light cystoscopy with CYSVIEW® in non-muscle invasive bladder cancer.
    Williams SB; Gavaghan MB; Fernandez A; Daneshmand S; Kamat AM
    Urol Oncol; 2022 Jan; 40(1):10.e7-10.e12. PubMed ID: 34158205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic impact of non-adherence to follow-up cystoscopy in non-muscle-invasive bladder cancer (NMIBC).
    Datovo JCF; Neto WA; Mendonça GB; Andrade DL; Reis LO
    World J Urol; 2019 Oct; 37(10):2067-2071. PubMed ID: 30805685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimal timing for the first cystoscopic follow-up using time-to-treatment initiation analysis of oncologic outcomes in primary non-muscle invasive bladder cancer.
    Kim JS; Lee J; Nguyen TT; Choi SY
    Sci Rep; 2024 Apr; 14(1):8440. PubMed ID: 38600160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Transurethral bladder resection of non muscle invasive bladder cancer with Hexvix ®].
    Seisen T; Rouprêt M
    Prog Urol; 2013 Nov; 23(14):1177-80. PubMed ID: 24176406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary markers in the everyday diagnosis of bladder cancer.
    Dal Moro F; Valotto C; Guttilla A; Zattoni F
    Urologia; 2013; 80(4):265-75. PubMed ID: 24419920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presence of Concomitant Non-muscle-invasive Bladder Cancer in Chinese Patients with Upper Tract Urothelial Carcinoma: Risk Factors, Characteristics, and Predictive Value.
    Fang D; Zhang L; Li X; Yu W; Singla N; Zhao G; Xiong G; Song Y; He Q; He Z; Zhou L
    Ann Surg Oncol; 2015 Aug; 22(8):2789-98. PubMed ID: 25564161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-muscle-invasive bladder cancer: a vision for the future.
    Malmström PU; Agrawal S; Bläckberg M; Boström PJ; Malavaud B; Zaak D; Hermann GG
    Scand J Urol; 2017 Apr; 51(2):87-94. PubMed ID: 28535714
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The role and method of fluorescence-guided cystoscopy in 2011 for management of bladder cancer: Review of the Oncology Committee of the French Urology Association].
    Wallerand H; Rouprêt M; Larré S; Houédé N; Neuzillet Y; Compérat E; Quintens H; Pignot G; Roy C; Soulié M; Pfister C;
    Prog Urol; 2011 Nov; 21(12):823-8. PubMed ID: 22035906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Influence of NBI Vision Over the First Follow-up Cystoscopy Outcomes in Newly Diagnosed NMIBC Patients.
    Geavlete B; Bulai C; Ene C; Checherita I; Geavlete P;
    Chirurgia (Bucur); 2015; 110(2):157-60. PubMed ID: 26011838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance?
    Loidl W; Schmidbauer J; Susani M; Marberger M
    Eur Urol; 2005 Mar; 47(3):323-6. PubMed ID: 15716195
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer.
    Todenhöfer T; Hennenlotter J; Guttenberg P; Mohrhardt S; Kuehs U; Esser M; Aufderklamm S; Bier S; Harland N; Rausch S; Gakis G; Stenzl A; Schwentner C
    BMC Cancer; 2015 Mar; 15():155. PubMed ID: 25884545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of an orthotopic rat bladder urothelial cell carcinoma model by cystoscopy.
    Hendricksen K; Molkenboer-Kuenen J; Oosterwijk E; Hulsbergen-van de Kaa CA; Witjes JA
    BJU Int; 2008 Apr; 101(7):889-93. PubMed ID: 18201266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An audit of positive findings in flexible and rigid check cystoscopy.
    Keoghane SR; Ritchie AW; Jones DJ
    J R Army Med Corps; 1999 Oct; 145(3):143-4. PubMed ID: 10579170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HAL blue-light cystoscopy in high-risk nonmuscle-invasive bladder cancer--re-TURBT recurrence rates in a prospective, randomized study.
    Geavlete B; Jecu M; Multescu R; Georgescu D; Geavlete P
    Urology; 2010 Sep; 76(3):664-9. PubMed ID: 20627289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reducing recurrence in non-muscle-invasive bladder cancer using photodynamic diagnosis and immediate post-transurethral resection of the bladder chemoprophylaxis.
    Lykke MR; Nielsen TK; Ebbensgaard NA; Zieger K
    Scand J Urol; 2015 Jun; 49(3):230-6. PubMed ID: 25731785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How different cystoscopy methods influence patient sexual satisfaction, anxiety, and depression levels: a randomized prospective trial.
    Krajewski W; Kościelska-Kasprzak K; Rymaszewska J; Zdrojowy R
    Qual Life Res; 2017 Mar; 26(3):625-634. PubMed ID: 28050795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
    Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
    BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of blue light flexible cystoscopy with hexaminolevulinate & the diagnosis of bladder cancer.
    Clinton TN; Lotan Y
    Future Oncol; 2018 Nov; 14(27):2805-2810. PubMed ID: 29925279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.